Company / Shareholders' Equity
STANDARD BIOTOOLS INC. Shareholders' Equity History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$471.7M
FY2025
5-year range
-$81.5M / $471.7M
FY2021-FY2025
Trend
+679.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity changed +679% YoY in FY2025, a notable deviation from the 9-year average annual change of +63%.
Based on SEC 10-K filings.
$472M in FY2025 with a 5-year CAGR of +45.6%.
Improved from $95M to $472M over the past 2 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +70.8%
- 5-Year CAGR
- +45.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +45.6%, indicating consistent growth.
- In FY2025, shareholders' equity increased 679.0% year-over-year.
- Lowest shareholders' equity in the period was in FY2024.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $471.7M | +679.0% |
| FY2024 | -$81.5M | -186.1% |
| FY2023 | $94.6M | +0.0% |
| FY2022 | $94.6M | -32.0% |
| FY2021 | $139.1M | +92.8% |
| FY2020 | $72.1M | +133.1% |
| FY2019 | $30.9M | -41.9% |
| FY2018 | $53.2M | -53.7% |
| FY2017 | $114.9M | -23.6% |
| FY2016 | $150.4M | +56.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026